Premium
GABA A ‐receptor modification in taurine transporter knockout mice causes striatal disinhibition
Author(s) -
Sergeeva O. A.,
Fleischer W.,
Chepkova A. N.,
Warskulat U.,
Häussinger D.,
Siebler M.,
Haas H. L.
Publication year - 2007
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jphysiol.2007.141432
Subject(s) - taurine , disinhibition , muscimol , bicuculline , medicine , gabaa receptor , endocrinology , chemistry , striatum , receptor , neuroscience , biology , biochemistry , amino acid , dopamine
The Striatum is involved in the regulation of movements and motor skills. We have shown previously, that the osmolyte and neuromodulator taurine plays a role in striatal plasticity. We demonstrate now that hereditary taurine deficiency in taurine‐transporter knock‐out (TAUT KO) mice results in disinhibition of striatal network activity, which can be corrected by taurine supplementation. Modification of GABA A but not glycine receptors (taurine is a ligand for both receptor types) underlies this disinhibition. Whole‐cell recordings from acutely isolated as well as cultured striatal neurons revealed a decreased agonist sensitivity of the GABA A receptor in TAUT KO neurons in the absence of changes in the maximal GABA‐evoked current amplitude. The striatal GABA level in TAUT KO mice was unchanged. The amplitude enhancement of spontaneous IPSCs by zolpidem was stronger in TAUT KO than in wild‐type (WT) animals. Tonic inhibition was absent in striatal neurons under control conditions but was detected after incubation with the GABA‐transaminase inhibitor vigabatrin: bicuculline induced a larger shift of baseline current in WT as compared to TAUT KO neurons. Lack of taurine leads to reduced sensitivity of synaptic and extrasynaptic GABA A receptors and consequently to disinhibition. These findings help in understanding neuropathologies accompanied by the loss of endogenous taurine, for instance in hepatic encephalopathy.